Primary tabs
The list of publications is indicative and may not include all publications.
Biomarkers in systemic sclerosis-related pulmonary arterial hypertension..
Curr Vasc Pharmacol. 9(2), 213-9.
(2011).
Natriuretic peptides in systemic sclerosis-related pulmonary arterial hypertension..
Semin Arthritis Rheum. 39(4), 278-84.
(2010).
Effects of renin-angiotensin system inhibition on left atrial function of hypertensive patients: an echocardiographic tissue deformation imaging study..
Am J Hypertens. 23(5), 556-61.
(2010).
Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis..
Clin Rheumatol. 29(9), 957-64.
(2010).
Scleroderma renal crisis accompanied by new-onset pulmonary arterial hypertension: an acute systemic endothelial injury? Case report and literature..
Inflamm Allergy Drug Targets. 9(4), 313-8.
(2010).
N-terminal pro-brain natriuretic peptide in systemic sclerosis related pulmonary arterial hypertension under bosentan treatment..
Rheumatol Int. 29(3), 347-8.
(2009).